FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/03/2026
Back to search
Official data from USPTO
EXOEDIT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXOEDIT
ST13
US500000079409929Class
5, 42, 44
Filing
79409929
Registration
8155579
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
06/04/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
06/18/2024
Registration date
03/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/03/2026
Last transaction
06/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CORWIN, CHARLOTTE K
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Evox Therapeutics Limited
Representatives
David P. Johnson Workman Nydegger
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; pharmaceutical preparations and substances for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; pharmaceutical preparationsa drug delivery system comprising genetically engineered or purified exosomes for therapeutic use; pharmaceutical preparationsexosomes to deliver protein or nucleic acids or viral vectors for therapy; medicine for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; medical preparations for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations for medical purposes for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies in the nature of mitochondrial diseasejoint and ligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; biological preparations comprising exosome for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations comprising a therapeutic target protein-loadednucleic acid-loaded or virus-loaded exosome for the treatment of genetic diseasesrespiratory diseasescancer; biological reagents for medical use; mixed biological preparations for medical purposes for the prevention and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; mixed biological preparations for the prevention and treatment of infectious diseases; extracellular vesicle-based nucleic acid preparations for therapeutical use for the prevention and treatment of infections or disease for the prevention and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies in the nature of mitochondrial diseasejoint and ligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; gene therapy productsgene delivery pharmaceuticals; pharmaceutical preparations for gene therapygene editinggenome editing; pharmaceutical preparations for use in gene therapies for the treatment of genetic diseases and disorders
Class 42
Scientificmedical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services in the field of pharmaceuticals; biological research; clinical research in the field of transformational therapeutics; providing medical research and scientific research information in the field of filtration of exosomes from cultured cells or blood; scientific investigations for medical purposes; scientific laboratory services; medical laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of genetic diseasescancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies such as mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; medical laboratory diagnostics research services; genetic engineering services; genetic research; research in the field of gene editing technology; research in the field of DNA mutation; informationadvisory and consultancy services relating to the aforesaid
Class 44
Medical services; medical and pharmaceutical consultancy; medical diagnostics; medical analysis for the diagnosis and treatment of persons and medical examinations; medical treatment services; medical screening; medical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerviral and bacterial based infections and diseases; medical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies such as mitochondrial diseasejoint and ligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; informationadvisory and consultancy services relating to the aforesaid
Publications
History of USPTO decisions and trademark events.
22 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/07/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/20/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/20/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/13/2026
PUBO
PUBLISHED FOR OPPOSITION
01/13/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/07/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/22/2025
RFNT
REFUSAL PROCESSED BY IB
02/09/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/22/2025
RFRR
REFUSAL PROCESSED BY MPU
01/22/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/24/2024
CNRT
NON-FINAL ACTION WRITTEN
12/23/2024
DOCK
ASSIGNED TO EXAMINER
12/19/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/22/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/22/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2024
Continuous trademark protection
Get notified about every new filing that threatens EXOEDIT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.